Factors which determine participation in an early detection program of cervical cancer in the state of Morelos;Factores que determinan la participacion en el tamizaje de cancer cervical en el estado de Morelos

Salud Publica de Mexico

Volumn 41, Issue 4, 1999, Pages 278-285

  Lazcano Ponce, Eduardo César ^a   Moss, Sue ^c   Cruz Valdez, Aurelio ^a   Alonso De Ruiz, Patricia ^c   Casares Queralt, Salvador ^b   Martínez León, Carlos Javier ^b   Hernández Avila, Mauricio ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c NONE

Author keywords

Cervix neoplasms; Early cancer detection; Mexico

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CONTRACEPTION; EARLY DIAGNOSIS; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; MEXICO; PAPANICOLAOU TEST; UTERINE CERVIX CANCER; ADOLESCENT; CROSS-SECTIONAL STUDY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; RANDOMIZATION; RISK FACTOR; SOCIOECONOMICS; STATISTICS; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MASS SCREENING; MEXICO; MIDDLE AGED; PATIENT COMPLIANCE; RANDOM ALLOCATION; RISK FACTORS; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032827066     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Robles S. Introduction to the special issue: Timely detection of cervical cancer. Bull Pan Am Health Organ 1996;30(4):285-189.
2. Beral V, Hermon C, Muñoz N, Devesa S. Cervical cancer. Cancer surv 1994:19/20:265-285.
3. Lazcano-Ponce E, Rascon R, Lozano R, Velasco E. Mortality from carcinoma of the uterine cervix in Mexico. Acta Cytol 1996;40:506-512.
4. Robles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 1996;30(4):290-301.
5. Lazcano-Ponce E, Alonso P, López L, Hernánduz M. Quality control study on negative gynecological cytology in Mexico. Diagn Cytopatholl 1994;10: 10-14.
6. Lazcano-Ponce E, Alonso P, López L, Nájera P, Avila R, Escandón C et al. Validity and reproducibility of cytology diagnosis in a sample cervical cancer screening centers in Mexico. Acta Cytol 1997;41:227-284.
7. Hernández M, Lazcano E, López L, Alonso P, Rojas R. Evaluación del programa de detección oportuna de cáncer cervical en México. Un estudio de casos y controles con base poblacional. Gac Med Mex 1994;130(4): 201-209.
8. Lazcano-Ponce E, Nájera P, Buiatti E, Alonso P, Kuri P, Cantoral L et al. The cervical cancer screening program in Mexico. Problems with access and coverage. Cancer Causes & Control 1997;8:693-704.
9. a.edición. College Station,TX: Stata Corporation, 1993.
10. Guiscafré H, Bronfman M, Padilla G, Reyes CM, Castro R, Muñoz O et al. Estrategias para mejorar patrones terapéuticos utilizados en diarrea aguda en unidades de atención médica primaria. II. Medición de la desigualdad: una propuesta metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med 1988;19(4):419-425.
11. Lazcano-Ponce E, Hernández M, López L, Alonso P, González G, Torres A et al. Factores de riesgo reproductivo e historia de vida sexual asociados a cancer cervical en una muestra de mujeres de la Ciudad de México. Rev Invest Clin 1995;47:377-385.
12. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985;38(11):27-36.
13. Sensky T. Eliciting lay beliefs across cultures: Principles and methodology. Br J Cancer 1996;74 suppl XXIX:S63-S65.
14. Sensky T. Patient's reactions to illness: Congnitive factors determine responses and are amenable to treatment. Br Med J 1990;300:622-623.
15. Luke K. Cervical cancer screening: Meeting the needs of minority ethnic women. Br J Cancer 1996;74 suppl XXIX:S47-S50.
16. Hunt SM, Macleod M. Health and behavioural change: Some lay perspectives. Community Med 1987;9:68-76.
17. Straton J, Holman C, Edwards B. Cervical cancer screening in Western Australia in 1992: Progress since 1983. Med J Aust 1993;159:657-661.
18. Conway-K. Attitudes to Papanicolaou smears. J Psychosom ObstetGynecol 1996;17(4):189-194.
19. Bergmann JB, Sigurdsson JA; Sigurdsson K. What attendance rate can be achieved for Pap smear screening? A case-control study of the characteristics of non-attenders and results of reminder efforts. Scand J Prim Health Care 1996;14(3):152-158.
20. Ponten J, Adami H, Bergstrom R, Dillner J, Friberg L, Gustafson L et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
21. Wilcox LS; Mosher WD. Factors associated with obtaining health screening among women of reproductive age. Public Health Rep 1993; 108(1):76-86.
22. Provost EM. Cervical cancer screening on theYukon-Kuskokwim Delta, Southwest Alaska: A population-based study. Cancer 1996;78(7):1598-1602.
23. Wang PD, Lin RS. Sociodemographic factors of Pap smear screening in Taiwan. Public Health 1996;110(2):123-127.
24. Bonelli L, Branca M, Ferreri M, Barizzone D, Rossi E, Cedri-S et al. Attitude of women towards early cancer detection and estimation of the compliance to a screening program for cervix and breast cancer. Cancer Detect Prev 1996;20(4):342-352.
25. Skaer TL, Robison LM, Sclar DA, Harding-GH. Cancer-screening determinants among Hispanic women using migrant health clinics. J Health Care Poor Underserved 1996;7(4):338-354.
26. Hubbell FA, Chávez LR, Mishra SI, Valdez RB. Beliefs about sexual behavior and other predictors of Papanicolaou smear screening among Latinas and Anglo women. Arch Intern Med 1996;156(20):2353-2358.
27. Price JH, Easton AN, Telljohann SK, Wallace PB. Perceptions of cervical cancer and Pap smear screening behavior by women's sexual orientation. J Community Health 1996;21(2):89-105.
28. Dignan M, Michielutte R, Blinson K, Wells HB, Case LD, Sharp P et al. Effectiveness of health education to increase screening for cervical cancer among Eastern-band Cherokee Indian women in North Carolina. J Natl Cancer Inst 1996;88(22):1670-1676.
29. Williams GA, Abbott RR, Taylor DK. Using focus group methodology to develop breast cancer screening programs that recruit African American women. J Community Health 1997;22(1):45-56.
30. Harmon MP, Castro FG, Coe K. Acculturation and cervical cancer: Knowledge, beliefs and behaviors of Hispanic women. Women Health 1996; 24(3):37-57.
31. Kelly AW, Del-Mar-Fores-Chacori M, Wollan PC, Trapp MA, Weaver AL, Barrier PA et al. A program to increase breast and cervical cancer screening for Cambodian women. Mayo Clin Proc 1996;71(5):437-444.
32. Cohen MM. Why is there no progress against cervical cancer? Can Med Assoc J 1996;154(12):1867-1869.
33. Strickland CJ, Chrisman NJ, Yallup M, Powell K, Squeoch MD. Walking the journey of womanhood:Yakama Indian women and Papanicolaou (Pap) test screening. Public Health Nurs 1996;13(2):141-150.
34. Skaer TL, Robison LM, Sclar DA, Harding GH. Knowledge, attitudes, and patterns of cancer screening: A self-report among foreign born Hispanic women utilizing rural migrant health clinics. J Rural Health 1996;12(3): 169-177.
35. Barbosa RM, Do-Lago TG, Kalckman S, Villela WV. Sexuality and reproductive health care in São Paulo, Brazil. Health Care Women Int 1996;17(5):413-421.